Transgenic over-expression of YY1 induces pathologic cardiac hypertrophy in a sex-specific manner

BL Stauffer, K Dockstader, G Russell, J Hijmans… - Biochemical and …, 2015 - Elsevier
BL Stauffer, K Dockstader, G Russell, J Hijmans, L Walker, M Cecil, K Demos-Davies
Biochemical and biophysical research communications, 2015Elsevier
YY1 can activate or repress transcription of various genes. In cardiac myocytes in culture
YY1 has been shown to regulate expression of several genes involved in myocyte
pathology. YY1 can also acutely protect the heart against detrimental changes in gene
expression. In this study we show that cardiac over-expression of YY1 induces pathologic
cardiac hypertrophy in male mice, measured by changes in gene expression and lower
ejection fraction/fractional shortening. In contrast, female animals are protected against …
Abstract
YY1 can activate or repress transcription of various genes. In cardiac myocytes in culture YY1 has been shown to regulate expression of several genes involved in myocyte pathology. YY1 can also acutely protect the heart against detrimental changes in gene expression. In this study we show that cardiac over-expression of YY1 induces pathologic cardiac hypertrophy in male mice, measured by changes in gene expression and lower ejection fraction/fractional shortening. In contrast, female animals are protected against pathologic gene expression changes and cardiac dysfunction. Furthermore, we show that YY1 regulates, in a sex-specific manner, the expression of mammalian enable (Mena), a factor that regulates cytoskeletal actin dynamics and whose expression is increased in several models of cardiac pathology, and that Mena expression in humans with heart failure is sex-dependent. Finally, we show that sex differences in YY1 expression are also observed in human heart failure. In summary, this is the first work to show that YY1 has a sex-specific effect in the regulation of cardiac pathology.
Elsevier